[صفحه اصلی ]   [Archive]  
:: صفحه اصلي درباره نشريه آخرين شماره تمام شماره‌ها جستجو ثبت نام ارسال مقاله تماس با ما ::
بخش‌های اصلی
صفحه اصلی::
اطلاعات نشریه::
آرشیو مجله و مقالات::
برای نویسندگان::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
دریافت اطلاعات پایگاه
نشانی پست الکترونیک خود را برای دریافت اطلاعات و اخبار پایگاه، در کادر زیر وارد کنید.
..
:: دوره 4، شماره 2 - ( 3-1394 ) ::
جلد 4 شماره 2 صفحات 251-249 برگشت به فهرست نسخه ها
Prevalence of Helicobacter Pylori in symptomatic patients post triple therapy eradication in Jordan
چکیده:   (8965 مشاهده)
Background and Objective: Despite the use of triple therapy for H.pylori eradication, significant number of the patients still has same complaint. In view of their complaint and increase number of the studies showed decrease in the cure rate of triple therapy, we look at the prevalence of Helicobacter Pylori (HP) in symptomatic patients post a fourteen days’ course of triple therapy in documented HP gastritis by histopathology. Method and Materials: A retrospective study, which includes one hundred and five patients, whom underwent endoscopies for epigastric pain, from May2014 till February 2015,and have had gastric biopsies that showed chronic active gastritis with presence of HP. Triple eradication therapy in the form of omperazole 20mg BID, amoxicillin 1g BID and clarithromycin 500mg BID was given for 14 days. These patients were selected as they remain symptomatic post eradication therapy. The presence of HP after eradication was confirmed by stool antigen test six weeks after the end of treatment with complete avoidance of antibiotics, proton pump inhibitors and histamine 2 receptor antagonists during this period. Result: The rate of eradication in these symptomatic patients was 61.9%. Failure of eradication was seen in 33.3% of the male group (10 patients) and 40% of the female group (30 patients). Conclusion: Our study showed that triple therapy eradication rate was 61.9%, which is lower than international findings this may be explained by fact that we only screened the symptomatic patient post eradication therapy and not all patients who received the course. Studies on HP sensitivity for antibiotic should be done to guide eradication regimens to reach acceptable eradication rates.
     
نوع مطالعه: پژوهشي | موضوع مقاله: عمومى
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tarif S B, Gamaz A, Khasawneh H, Al Shebli H, Al Sharari D. Prevalence of Helicobacter Pylori in symptomatic patients post triple therapy eradication in Jordan. Int J Med Invest 2015; 4 (2) :249-251
URL: http://intjmi.com/article-1-135-fa.html

Prevalence of Helicobacter Pylori in symptomatic patients post triple therapy eradication in Jordan. . 1394; 4 (2) :249-251

URL: http://intjmi.com/article-1-135-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 4، شماره 2 - ( 3-1394 ) برگشت به فهرست نسخه ها
International Journal of Medical Investigation
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4645